AP Biosciences, Inc. · TPEX:6945

AP Biosciences, Inc. financial statements

AP Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue0032.3M06.99M137.6M
Cost of revenue017.5M08.68M0
Gross profit0-17.5M32.3M-8.68M6.99M137.6K
Research and development369.8M365.4M336.6M262.7M173.8M66.8M
Selling, general and administrative86.6M73.1M43.1M34.8M19.9M
Operating income-456.4M-439.1M-347.5M-288.5M-186.7M45.0M
Depreciation and amortization25.5M17.5M12.6M8.68M8.86M7.20K
EBITDA-430.9M-421.6M-334.9M-279.9M-177.9M45.0M
Interest expense1.42M1.65M1.20M0
Income before tax-444.8M-422.7M-339.3M-288.5M-187.6M41.7M
Net income-444.8M-422.7M-339.3M-288.5M-187.6M41.7K
Earnings per share, basic-5.20-5.61-5.24-5.48-3.890.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents970.9M1.44B278.6M1.05B527.1M630.7K
Short-term investments200.0M100.0M461.4M30.7M30.0M
Receivables4.89M2.62M1.03M17.0K105
Current assets1.22B1.58B765.6M1.09B563.9M632.3K
Total assets1.37B1.73B890.8M1.10B579.3M652.0K
Current liabilities40.8M39.7M30.9M4.52M21.1M9.16K
Total debt70.9M82.1M
Total liabilities94.2M104.4M106.7M4.52M21.1M9.16K
Shareholders' equity1.27B1.62B784.1M1.10B558.2M642.9K
Shares outstanding85.6M75.3M64.7M52.6M48.2M48.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-352.1M-357.9M-297.6M-276.0M-168.7M-17.0K
Capital spending-25.3M-5.53M-35.4M-2.43M-4.91M-7.25K
Free cash flow-377.3M-363.4M-333.0M-278.4M-173.6M-24.3K
Cash from investing326.4M-468.7M-3.15M-34.9M-7.30K
Cash from financing1.20B-3.10M800.0M100.0M581.1K
Change in cash-470.8M1.16B-769.4M520.9M-103.6M556.8K